Clinical Research Directory
Browse clinical research sites, groups, and studies.
Collection of Samples From the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance
Sponsor: Universal Diagnostics
Summary
This study is designed to prospectively collect blood samples and clinical data from patients that have been newly diagnosed with colorectal cancer and scheduled for resection surgery but are pre cancer treatment, subjects who are NOT scheduled for surgery but have histological confirmation of CRC from the diagnostic colonoscopy and clinical staging (cTMN) is available and are pr e- treatment, and patients who are at average risk of colorectal cancer and who are scheduled for routine colonoscopy examinations.
Official title: Collection of Samples From the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance (PROVE)
Key Details
Gender
All
Age Range
45 Years - 84 Years
Study Type
OBSERVATIONAL
Enrollment
6500
Start Date
2023-07-31
Completion Date
2027-07
Last Updated
2025-12-30
Healthy Volunteers
Yes
Conditions
Locations (1)
Gastroenterology and Internal Medicine Specialists
Lake Barrington, Illinois, United States